raseliarison
nirinA
adrien
blog
code
FAQ

home
news
- arXiv
  - astro-ph
  - cond-mat
  - cs
  - eess
  - gr-qc
  - hep-ex
  - hep-lat
  - hep-ph
  - hep-th
  - math
  - math-ph
  - nlin
  - nucl-ex
  - nucl-th
  - physics
  - q-bio
  - quant-ph
  - stat
- physics
  - phys.org
  - physics world
- linux
  - kernel
  - slackware
- nature
  - natcomputsci
  - natastron
  - natbiomedeng
  - nenergy
  - nnano
  - natmachintell
  - nbt
  - nmeth
  - natecolevol
  - nmicrobiol
  - ng
  - nchembio
  - natelectron
  - micronano
  - nphoton
- bioRxiv
- plos one
- world
  - BBC
  - Al Jazeera
- earth
- universe
  - apod
  - hubble
  - atel
  - nasa
wiki
gemini

Nature Biotechnology

Nature Biotechnology is a monthly journal publishing new concepts in biological technology of relevance to bioengineering, medicine, energy, agriculture, food and the environment. It has a magazine covering the commercial, political, ethical, legal and societal aspects of this research.

Targeting glycans for cancer immunotherapy

https://www.nature.com/articles/s41587-025-02924-1

Antibody-lectin chimeras for glyco-immune checkpoint blockade

https://www.nature.com/articles/s41587-025-02884-6

Jessica C. Stark

FDA pitches new pathway for rare genetic diseases

https://www.nature.com/articles/s41587-025-02967-4

Biotech news from around the world

https://www.nature.com/articles/s41587-025-02958-5

Novel anti-malarial aces phase 3

https://www.nature.com/articles/s41587-025-02968-3

Metagenomic editing integrates large DNA sequences into gut bacteria in vivo

https://www.nature.com/articles/s41587-025-02966-5

Rong Li

Liquid biopsy

https://www.nature.com/articles/s41587-025-02940-1

FDA approves triglyceride-lowering siRNA drug

https://www.nature.com/articles/s41587-025-02969-2